Skip to main content
OpenTrials
Completed

NCT Number: NCT06289400

Magnetic Field Application in Patellofemoral Pain Syndrome

The purpose of this study is to examine the effect of magnetic field application used in the treatment of patellofemoral pain.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pain, Knee Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

KTO Karatay University

Konya, Turkey (Türkiye)

About this study

The aim of this randomized controlled study is to examine the effect of magnetic field application used in the treatment of patellofemoral pain.

The main question it aims to answer is;

Is magnetic field therapy applied in addition to conventional treatment effective in reducing pain in individuals with Patellofemoral pain syndrome?

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Having been diagnosed with patellofemoral pain syndrome by an orthopedic physician
  • Volunteering to participate in the study
  • Having pain for more than eight weeks
  • Patients who did not undergo surgery

Exclusion criteria

  • Patients diagnosed with rheumatological disease
  • Patients who have previously had steroid injections in the knee area
  • Patients with entrapment neuropathy and deformity in the lower extremity
  • Patients who are pregnant
  • Patients suffering from scoliosis,
  • Patients who use non-steroidal anti-inflammatory and antidepressant regularly for any reason

Treatment and study plan

Magnetic field application

Device

The applicator (Size: 15x15 cm) has placed 1-3 cm above the skin surface at the painful area. During the treatment, treatment has applied with ready-made protocols included in the device.

conventional treatment

Other

Within the scope of conventional treatment, hotpack application, transcutaneous electrical stimulation (TENS), interferential current and ultrasound treatment modalities will be applied. In addition, strengthening exercises will be applied to the muscles around the hip and knee and stretching exercises will be applied to the short muscle groups.

Primary outcomes

  1. Visual Analogue Scale (VAS)

    Time frame: The evaluation will be applied at the beginning of the treatment program.

    A Visual Analogue Scale (VAS) is one of the pain rating scales.Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain.

  2. 36-Item Short Form Survey (SF-36)

    Time frame: The evaluation will be applied at the beginning of the treatment program.

    The SF-36 is a 36-item self-report measure of health-related quality of life. It has eight subscales measuring different domains of health-related quality of life: physical functioning (PF), role-physical (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role-emotional (RE), and mental health (MH).

  3. Manual Muscle Test

    Time frame: The evaluation will be applied at the beginning of the treatment program.

    Manual muscle testing is based on the physiotherapist manually applying resistance to the muscle or muscle group to be evaluated.

  4. The Lower Extremity Functional Scale (LEFS)

    Time frame: The evaluation will be applied at the beginning of the treatment program.

    The Lower Extremity Functional Scale (LEFS) is a questionnaire containing 20 questions about a person's ability to perform everyday tasks. The LEFS can be used by clinicians as a measure of patients' initial function, ongoing progress and outcome, as well as to set functional goals.

Sponsors and collaborators

Lead sponsor

KTO Karatay University

Other

Registry information

Official study title

Investigating the Effect of Magnetic Field Application Used in Patellofemoral Pain Syndrome

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Mar 1, 2024
Registry last updated
Dec 4, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.